Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.
Hamed KhaliliÅsa H EverhovJonas HalfvarsonJonas F LudvigssonJohan AsklingPär MyrelidJonas SöderlingOla OlenMartin Neoviusnull nullPublished in: Alimentary pharmacology & therapeutics (2020)
In Sweden, the societal cost of incident and prevalent CD and UC patients was consistently two to three times higher than the general population.